Skip to main content
SpringerLink
Log in

Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The effect of growth hormone-releasing factor (GRF) 1-44 on growth hormone and somatostatin release in plasma has been studied in 20 obese children. Twenty age and sex-matched children with normal weight served as controls. Mean peak growth hormone response in obese children after 1 μg/kg body wt. GRF 1-44 was significantly lower than in controls (23.7±3.6 ng/ml vs. 41.1±3.0 ng/ml;P<0.01), as were mean integrated growth hormone response areas (1544±272 ng×ml-1×2 h vs. 2476±283 ng×ml-1×2 h;P<0.01). Mean plasma levels of somatostatin-like immunoreactivity did not change after GRF in both goups. Mean somatomedin-C levels in obese children were significantly higher compared to controls (1.6±0.4 U/ml vs. 0.86±0.4 U/ml;P<0.01). Somatomedin-C levels were not related to the integrated growth hormone responses. In conclusion there is no relation between somatomedin-C levels and the reduced growth hormone-releasing effect of GRF in obese children. GRF does not alter peripheral somatostatin-like immunoreactivity levels either in normal or obese children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

Sm-C:

somatomedin C

GRF:

growth hormone-releasing factor

GH:

growth hormone

SLI:

somatostatin-like immunoreactivity

References

  1. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL (1981) Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212:1279–1280

    Google Scholar 

  2. Berelowitz M, Finkelstein JA, Thominet JL, Ting NC, Hirth J, Frohman LA (1983) Impaired growth hormone secretion in spontaneous experimental obesity: a result of increased somatostatin (SRIF) tone. Presented at the annual meeting of the Endocrine Society, San Antonio, Texas, June 8–10

  3. Binet E, Schlumberger A, Chaussain JL, Job JC (1976) Serum somatomedin acitivity in obesity. In: Laron Z (ed) The Adipose Child. Karger, Basel, pp 153–156

    Google Scholar 

  4. Bucher H, Zachmann M, Illig R, Walter H, Manella B, Santamaria L, Prader A (1981) Response of adrenal steroids (AS), prolactin (PRL) and insulinlike-growth-factor I (IGF I) to high dose estrogens (HDE) in pubertal girls. Pediatr Res 15:83 (abstract)

    Google Scholar 

  5. Chihara K, Arimura A, Schally AV (1979) Immunoreactive somatostatin in rat hypophyseal blood: Effects of anesthetics. Endocrinology 104:1434–1441

    Google Scholar 

  6. Clemmons DR, Underwood LE, Dickerson RN, Brown RO, Hak LJ, Macphee RD, Heizer WD (1985) Somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients. Am J Nutr 41:191–198

    Google Scholar 

  7. Copinschi G, Delaet MH, Brion JP (1978) Simultaneous study of cortisol, growth hormone, and prolactin nyctohemeral variations in normal and obese subjects: Influence of prolonged fasting in obesity. Clin Endocrinol 9:15–26

    Google Scholar 

  8. Engelhardt W, Schwille PO, Hanisch E (1983) Improved radioimmunoassay for somatostatin in unextracted plasma using an acidic assay diluent. IRCS Med Sci 11:581–582

    Google Scholar 

  9. Furlanetto RE, Underwood LE, Van Wyk JJ, D'Ercole AJ (1977) Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest 60:648–657

    Google Scholar 

  10. Glass AR, Burman KD, Dahma WT, Boehm TM (1981) Endocrine function in human obesity. Metabolism 30:89–104

    Google Scholar 

  11. Gustavsson S, Lundqvist G (1982) Release of insulin and pancreatic somatostatin in response to increased circulating growth hormone levels. Ups J Med Sci 87:127–134

    Google Scholar 

  12. Hintz RL, Suskind R, Amatayakul K, Thanangkul O, Olson R (1978) Plasma somatomedin and growth hormone values in children with protein-calorie malnutrtion. J Pediatr 92:153–156

    Google Scholar 

  13. Hizuka N, Takano K, Shizume K, Hirose N, Ling N (1984) Plasma growth hormone responses to repetitive administrations of growth hormone releasing factor in patients with pituitary dwarfism. Endocrinol Jpn 31:697–704

    Google Scholar 

  14. Kopelman PG, Noonan K, Goulton R, Forrest AJ (1985) Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycemia in obesity. Clin Endocrinol 23:87–94

    Google Scholar 

  15. Phillips LS, Vassilopoulou-Sellin R (1979) Nutritional regulation of somatomedin. Am J Nutr 32:1082–1096

    Google Scholar 

  16. Phillips LS, Belosky CD, Young HS, Reichard LA (1979) Nutrition and somatomedin. IV Somatomedin activity and somatomedin inhibitory activity in sera from normal and diabetic rats. Endocrinology 104:1519–1524

    Google Scholar 

  17. Puttkamer K v, Bierich JR, Brugger F, Hirche W, Schönberg D (1977) Östrogentherapie bei Mädchen mit konstitutionellem Hochwuchs. Dtsch Med Wochenschr 102:983–988

    Google Scholar 

  18. Quabbe JH, Helge H, Kubicki S (1971) Nocturnal growth hormone secretion: Correlation with sleeping EEG in adults and pattern in children and adolescents with nonpituitary dwarfism, over-growth, and with obesity. Acta Endocrinol (Copenh) 67:767–783

    Google Scholar 

  19. Skamene A, Pater YC (1984) Infusion of graded concentrations of somatostatin in man: pharmacocinetics and differential inhibitory effects on pituitary and islet hormones. Clin Endocrinol 20:555–564

    Google Scholar 

  20. Takano K, Hizuka N, Shizume K, Honda N, Ling NC (1985) Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hGRF-44) in normal and GH deficient children. Acta Endocrinol (Copenh) 108:11–19

    Google Scholar 

  21. Tannenbaum GS, Ling N (1984) The interrelationship of growth hormone (GH) — releasing factor and somatostatin in generation of the ultradian rhytm of GH secretion. Endocrinology 115:1952–1957

    Google Scholar 

  22. Tanner JM (1962) Growth at adolescence. Blackwell, Oxford

    Google Scholar 

  23. Tanner JM, Whitehouse RH, Takaishi M (1966) Standards from birth to maturity for height, weight, height velocity and weight velocity. British children. Arch Dis Child 41:454–471; 613–635

    Google Scholar 

  24. Van den Brande JL, Du Caju MVL (1974) Plasma somatomedin activity in children. Acta Endocrinol [Suppl] ((Copenh) 184:195–196

    Google Scholar 

  25. Wehrenberg WB, Ling N, Böhlen P, Esch F, Brazeau P, Guillemin R (1982) Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochem Biophys Res Commun 109:562–567

    Google Scholar 

  26. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone responses to growth hormone releasing factor in obesity: A pituitary defect reversed with weight reduction. N Engl J Med 311:1403–1407

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Kinderklinik, Adenauerallee 119, D-5300, Bonn, Federal Republic of Germany

    R. Rosskamp, M. Becker & S. Soetadji

Authors
  1. R. Rosskamp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Soetadji
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosskamp, R., Becker, M. & Soetadji, S. Circulating somatomedin-C levels and the effect of growth hormone-releasing factor on plasma levels of growth hormone and somatostatin-like immunoreactivity in obese children. Eur J Pediatr 146, 48–50 (1987). https://doi.org/10.1007/BF00647283

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00647283

Key words

Search

Navigation